Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-03T01:32:33.375Z Has data issue: false hasContentIssue false
  • English
  • Français

Vaccination against Klebsiella aerogenes

Published online by Cambridge University Press:  19 October 2009

E. A. Roe  and
R. J. Jones
E. A. Roe
Affiliation:
MRC. Vaccine Research Laboratories, Clinical Research Block, Medical School, Vincent Drive, Birmingham B15 2TJ
R. J. Jones
Affiliation:
MRC. Vaccine Research Laboratories, Clinical Research Block, Medical School, Vincent Drive, Birmingham B15 2TJ
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Klebsiella vaccine was prepared from strains of Klebsiella aerogenes with capsular types Kl, K36, K44 and K Cross (a type which cross-reacts in vitro with sera from many klebsiella capsular types). The vaccine was extracted by dialysis and ultrafiltration from capsular material released during growth of the bacteria in a five-day batch culture.

Mice given one dose of vaccine from K1a (l·0 μg/mouse) survived lethal intraperitoneal challenge of 11/11 homologous klebsiella strains four days after vaccination; 14 days after vaccination protection against the same challenge strains had declined to 5/11 strains. Vaccines from Kla, b, c, K3G, K44 and K Cross induced homologous protection and protected mice against different ranges of heterologous klebsiella capsular types.

The protective response of the mice was greatly enhanced by administering three doses of the vaccines. Vaccines from Kl, K36, K44 and K Cross protected mice against 14/20, 11/20, 10/20 and 9/20 homologous and heterologous klebsiella challenge strains respectively.

None of the klebsiella vaccines was toxic for mice at the immunizing dose (l·0 μg/mouse). Vaccine from K36 was the most lethal, killing mice at 103 immunizing doses. The least toxic vaccine was from K44, which killed mice at 104 immunizing doses.

Type
Research Article
Information
Journal of Hygiene , Volume 93 , Issue 2 , October 1984 , pp. 355 - 363
Copyright
Copyright © Cambridge University Press 1984

References

Alexander, J. W., Fisher, M. W., MacMillan, B. G. & Altemeir, W. A. (1969). Prevention of invasive pseudomonas infection in burns with a new vaccine. Archives of Surgery 99, 249–257.CrossRefGoogle ScholarPubMed
Bryan, C. S., Reynolds, K. L. & Brenner, E. R. (1983). Analysis of 1,186 episodes of Gram-negative bacteraemia in non-university hospitals: the effects of antimicrobial therapy. Reviews of Infectious Diseases 5, 629–638.CrossRefGoogle Scholar
Carney, S. A. & Jones, R. J. (1968). Biological and immunochemical properties of culture filtiates of virulent strains of Pseudomonas aeruginosa. British Journal of Experimental Pathology 49, 395–410.Google Scholar
Casewell, M. W. (1982). The role of multiple resistant coliforms in hospital acquired infection. In Recent Advances in Infection (ed. Reeves, D. S. and Geddes, A. M.), pp. 31–50. Edinburgh: Chuchill Livingstone.Google Scholar
Casewell, M. W. & Talsania, N. G. (1979). Predominance of certain klebsiella capsular types in hospitals in the United Kingdom. Journal of Infection 1, 77—79.CrossRefGoogle Scholar
Cryz, S. J. (1983). Progress in immunisation against klebsiella infections. European Journal of Clinical Microbiology 2, 523–528.Google Scholar
Davis, B. D., Lilly, H. A. & Lowbury, E. J. L. (1968). Gram-negative bacilli in burns. Journal of Clinical Pathology 22, 634–640.Google Scholar
Domenico, P., Johanson, W. G. & Strauss, D. C. (1982). Lobular pneumonia in rats produced by clinical isolates of klebsiella pneumonia. Infection and Immunity 37, 327—335.Google Scholar
Feller, I. (1966). The use of pseudomonas vaccine and hyperimmune plasma in the treatment of seriously burned patients. In Research in Burns (ed. Wallace, A. B. and Wilkinson, A. W.), pp. 470–474. Edinburgh: Livingstone.Google Scholar
Jones, R. J. (1981). Vaccines and nntisera against Gram-negative bacilli. Journal of Hospital Infection 2, 105–111.Google Scholar
Jones, R. J. (1983). Immunisation against pseudomonas infection. In Immunisation against Bacterial Disease. (Medical Microbiology, Volume 2) (ed. Easmon, C. S. F. and Jeljaszewicz, J.), pp. 177—205. London and New York: Academic Press.Google Scholar
Jones, R. J., Roe, E. A. & Gupta, J. L. (1980). Controlled trial of pseudomonas immunoglobulin and vaccine in burned patients. Lancet 2, 1263–1266.CrossRefGoogle Scholar
Kreger, B. E., Craven, D. E., Carling, P. C. & McCabe, W. R. (1980). Gram-negative bacteraemia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. American Journal of Medicine 68, 332–355.Google Scholar
Liu, P. V. (1964). Factors that influence toxigenicity of Pseudomonas aeruginosa. Journal of Bacteriology 88, 1421–1427.Google Scholar
Montgomerie, J. Z. (1979). Epidemiology of klebsiella hospital associated infections. Reviews of Infectious Diseases 1, 736–753.CrossRefGoogle ScholarPubMed
Nakashima, I. & Kato, N. (1977). Adjuvant action of capsular polysaccharide of K, pneumoniae in antibody response. VI. Site of its action. Zeitschrift für Immunitätsforschung 153, 204–216.Google Scholar
Orskov, I. (1956). Immunological paralysis induced in rabbits by a heavily capsulated klebsiella strain. Acta Pathologica et Microbiologica Scandinavica 38, 375–384.Google Scholar
Palfreyman, J. M. (1978). Klebsiella serotyping by counter-current immunoelectrophoresis. Journal of Hygiene 81, 219–226.CrossRefGoogle ScholarPubMed
Pollack, M. (1976). Significance of circulating capsular antigen in klebsiella infections. Infection and Immunity 40, 56–61.Google Scholar
Riottot, M., Fournier, M. J. & Jouin, H. (1981). Direct evidence of the involvement of capsular polysaccharide in the immuno-protective activity of Klebsiella jmeumoniae in ribosomal preparations. Infection and Immunity 31, 71–79.Google Scholar
Riser, E. & Noone, P. (1981). Klebsiella capsular type versus site of isolation. Journal of Clinical Pathology 34, 552–555.CrossRefGoogle ScholarPubMed
Robbins, J. B., Schnkerson, R., Egan, W. B., Vann, W. & Liu, D. T. (1980). Virulence properties of bacterial capsular polysaccharides – unanswered questions. In The Molecular basis of Microbial Pathogenicity (ed. Smith, H., Skepel, J. J. and Turner, M. J.), pp. 115–132. Weinheim: Verlag Chemie.Google Scholar
Roe, E. A. & Jones, R. J. (1983). Immunisation of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Dehli. Reviews of Infectious Diseases 5. supplement 5, S922–930.Google Scholar
Smith, S. M., Diggri, J. T. & Eng, R. H. K. (1982). Epidemiology of klebsiella antibiotic resistance and serotypes. Journal of Clinical Microbiology 16, 868–873.CrossRefGoogle ScholarPubMed
Thomas, F. E., Jackson, R. J., Melly, M. A. & Alford, R. H. (1977). Sequential hospital wide outbreaks of resistant serratia and klebsiella infections. Archives of Internal Medicine 137, 581–584.CrossRefGoogle Scholar
Williams, P., Lambert, P. A., Brown, M. R. W. & Jones, R. J. (1983). The role of the 0 & K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. Journal of General Microbiology 129, 2181–2191.Google Scholar
Yokochi, T., Nakashima, I. & Kato, N. (1979). Further studies on generation of macrophages in in vitro cultures of mouse spleen cells and its inhibition by the capsular polysaccharide of Klebsiella pneumoniae. Microbiology and Immunology 23, 487–499.CrossRefGoogle ScholarPubMed
Young, S. E. J. (1982). Bacteraemia (1975–1980): a survey of cases reported to PHLS Communicable Disease Surveillance Centre. Journal of Hospital Infection 5, 19–26.CrossRefGoogle Scholar
Zlegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., C., Sadoff. J., Douglas, H. & Braude, A. I. (1982). Treatment of Gram-negative bacteraemia and shock with human antiserum to a mutant Escherichia coli. New England Journal of Medicine 307, 1225–1230.CrossRefGoogle Scholar
Zinner, S. H. & Peter, G. (1983). The potential role of cell wall core glycolipids in the immunotherapy of Gram-negative rod bacteraemia. In Immunisation against Bacterial Disease (Medical Microbiology, Volume 2) (ed. Easmon, C. S. F. and Jeljaszewicz, J.), pp. 71–87. London and New York: Academic Press.Google Scholar